Regulatory23 Sep 2026 · 8:41 AM IST
GLENMARKGlenmark Pharmaceuticals
US FDA closes its Goa plant inspection with a VAI classification
The company received the inspection report for its Goa facility.
Price, Tuesday's close₹2,461.40▲ 0.47%
Last 5 days
What happened
- Glenmark Pharmaceuticals received an Establishment Inspection Report (EIR) from the US FDA for its Goa facility, with a VAI classification.
Why it matters
Good to know: VAI stands for Voluntary Action Indicated: inspectors noted issues, but the FDA does not plan regulatory action.
Read the source
This is a summary of public news about Glenmark Pharmaceuticals, for information only. It is not a recommendation to buy, sell or hold GLENMARK.
Glenmark Pharmaceuticals in the news before
- 11 SEP 2026 · BUSINESS UPDATESLaunches Ryaltris in Brazil